Michael L. Salgaller

4.8k citations

53 papers · 4.0k indexed · h-index 28

Immunology top 0.5%
- Immunotherapy and Immune Responses 40
- T-cell and B-cell Immunology 15
- Immune Cell Function and Interaction 14
Oncology top 2%
- CAR-T cell therapy research 12
- Cancer Immunotherapy and Biomarkers 10
Molecular Biology top 5%
- vaccines and immunoinformatics approaches 11
- RNA Interference and Gene Delivery 8
Radiology, Nuclear Medicine and Imaging top 5%
- Monoclonal and Polyclonal Antibodies Research 6
Biotechnology top 5%

Co-authors: Steven A. Rosenberg S A Rosenberg Licia Rivoltini Francesco M. Marincola Alessandro Sette Yutaka Kawakami Scott Southwood Patricia A. Lodge
Cited by: Immunology Oncology Molecular Biology
Journals: The Journal of Immunology (3 papers)Cancer (1 paper)Biochemical and Biophysical Research Communications (2 papers)
Partner nations: United States Malaysia Italy

In The Last Decade

Michael L. Salgaller

51 papers receiving 3.9k citations

Peers

Countries citing papers authored by Michael L. Salgaller

Since Specialization

Citations

This map shows the geographic impact of Michael L. Salgaller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael L. Salgaller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael L. Salgaller more than expected).

Fields of papers citing papers by Michael L. Salgaller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael L. Salgaller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael L. Salgaller. The network helps show where Michael L. Salgaller may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michael L. Salgaller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael L. Salgaller Line = papers co-authored together Michael L. Salgaller links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Biotechnology entrepreneurship : from science to solutions Michael L. Salgaller	2010	0
2	Current Methods for Loading Dendritic Cells With Tumor Antigen for the Induction of Antitumor Immunity Journal of Immunotherapy ·Yaling Zhou,Marnix L. Bosch,Michael L. Salgaller	2002	83
3	Serological Cloning of PARIS-1: A New TBC Domain-Containing, Immunogenic Tumor Antigen from a Prostate Cancer Cell Line Biochemical and Biophysical Research Communications ·Yaling Zhou,Monica Toth,M.Shane Hamman,Steven Monahan,Patricia A. Lodge,Alton L. Boynton,Michael L. Salgaller	2002	29
4	American Association for Cancer Research Expert Opinion on Investigational Drugs ·Michael L. Salgaller	2000	376
5	Expression and Purification of Prostate-Specific Membrane Antigen in the Baculovirus Expression System and Recognition by Prostate-Specific Membrane Antigen-Specific T Cells Journal of Immunotherapy ·Patricia A. Lodge,Ronnie A. Childs,Steven Monahan,Joanne G. McLean,Anil Sehgal,Alton L. Boynton,Michael L. Salgaller,Gerald P. Murphy	1999	8
6	Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: A phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease The Prostate ·G.P. Murphy,B.A. Tjoa,S.J. Simmons,Justin Jarisch,Victoria Bowes,Haakon Ragde,M. Rogers,A. Elgamal,Gerald M. Kenny,Oliver E. Cobb,Robert C. Ireton,M.J. Troychak,Michael L. Salgaller,Alton L. Boynton	1999	197
7	Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides The Prostate ·B.A. Tjoa,S.J. Simmons,Victoria Bowes,Haakon Ragde,M. Rogers,A. Elgamal,Gerald M. Kenny,Oliver E. Cobb,Robert C. Ireton,M.J. Troychak,Michael L. Salgaller,Alton L. Boynton,G.P. Murphy	1998	207
8	Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA) The Prostate ·Michael L. Salgaller,Patricia A. Lodge,Joanne G. McLean,B. A. Tjoa,Douglas J. Loftus,Haakon Ragde,Gerald M. Kenny,M. Rogers,Alton L. Boynton,Gerald P. Murphy	1998	95
9	Uveal melanomas contain antigenically specific and non-specific infiltrating lymphocytes Current Eye Research ·Bruce R. Ksander,David C. Geer,Peter W. Chen,Michael L. Salgaller,Patrick E. Rubsamen,Timothy G. Murray	1998	29
10	Use of cellular and cytokine adjuvants in the immunotherapy of cancer Journal of Surgical Oncology ·Michael L. Salgaller,Patricia A. Lodge	1998	57
11	Monitoring of Cancer Patients Undergoing Active or Passive Immunotherapy Journal of Immunotherapy ·Michael L. Salgaller	1997	16
12	MAGE-1 andMAGE-3 or-6 expression in neuroblastoma-related pediatric solid tumors International Journal of Cancer ·Hiroyuki Ishida,Takafumi Matsumura,Michael L. Salgaller,Yoshikazu Ohmizono,Yosuke Kadono,Tadashi Sawada	1996	27
13	Analysis of Expression of the Melanoma-Associated Antigens MART-1 and gp lOO in Metastatic Melanoma Cell Lines and in In Situ Lesions Journal of Immunotherapy ·Francesco M. Marincola,Yasmine M. Hijazi,Patricia Fetsch,Michael L. Salgaller,Licia Rivoltini,Janice N. Cormier,Toni B. Simonis,Paul H. Duray,Meenhard Herlyn,Yutaka Kawakami,Steven A. Rosenberg	1996	113
14	Differential Anti-MART-1/MelanA CTL Activity in Peripheral Blood of HLA-A2 Melanoma Patients in Comparison to Healthy Donors Journal of Immunotherapy ·F.M. Marincola,Licia Rivoltini,Michael L. Salgaller,Michael J. Player,S A Rosenberg	1996	102
15	Synergistic Effects of IL-6 and IFN-γ on Carcinoembryonic Antigen (CEA) and HLA Expression by Human Colorectal Carcinoma Cells: Role for Endogenous IFN-β Cytokine ·Claudio Dansky-Ullmann,Michael L. Salgaller,Sharon Adams,Jeffrey Schlom,John W. Greiner	1995	46
16	HLA Associations in the Antitumor Response Against Malignant Melanoma Journal of Immunotherapy ·Francesco M. Marincola,Peter Shamamian,Licia Rivoltini,Michael L. Salgaller,Janice Cormier,Nicholas P. Restifo,Toni B. Simonis,David Venzon,Donald E. White,David Parkinson	1995	41
17	Generation of specific anti-melanoma reactivity by stimulation of human tumor-infiltrating lymphocytes with MAGE-1 synthetic peptide Cancer Immunology Immunotherapy ·Michael L. Salgaller,Jeffrey S. Weber,Scott Koenig,John R. Yannelli,Steven A. Rosenberg	1994	53
18	Evaluation of human carcinoembryonic-antigen (CEA)-transduced and non-transduced murine tumors as potential targets for anti-CEA therapies Cancer Immunology Immunotherapy ·Patricia Horan Hand,Paul F. Robbins,Michael L. Salgaller,Diane J. Poole,Jeffrey Schlom	1993	27
19	In situ hybridization with single-stranded RNA probes to demonstrate infrequently elevated gli mRNA and no increased ras mRNA levels in meningiomas and astrocytomas Cancer Letters ·Michael L. Salgaller,Dennis K. Pearl,R. E. Stephens	1991	20
20	Application of automated image analysis to demonstrate the correlation between ras p21 expression and severity of gliomas Biochemical and Biophysical Research Communications ·Michael L. Salgaller,Lawrence M Agius,Allan J. Yates,Dennis K. Pearl,William H. Roberts,Ralph E. Stephens	1990	15

About Michael L. Salgaller

Michael L. Salgaller is a scholar working on Immunology, Oncology and Biological Psychiatry, having authored 53 papers that have together received 4.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (40 papers), T-cell and B-cell Immunology (15 papers), Immune Cell Function and Interaction (14 papers), CAR-T cell therapy research (12 papers), vaccines and immunoinformatics approaches (11 papers), Cancer Immunotherapy and Biomarkers (10 papers), RNA Interference and Gene Delivery (8 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). The work is most often cited by research in Immunology (3.0k citations), Oncology (1.6k citations) and Molecular Biology (1.9k citations). Michael L. Salgaller has collaborated with scholars based in United States, Malaysia and Italy. Frequent co-authors include Steven A. Rosenberg, S A Rosenberg, Licia Rivoltini, Francesco M. Marincola, Alessandro Sette, Yutaka Kawakami, Scott Southwood, Patricia A. Lodge, Alton L. Boynton and Janice N. Cormier. Their work appears in journals such as The Journal of Immunology, Cancer and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact